# JANUMET XR

NDC: 0006-0080
Generic name: sitagliptin and metformin hydrochloride
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20120202

FDA application: NDA202270

## Active ingredients

- METFORMIN HYDROCHLORIDE: 1000 mg/1
- SITAGLIPTIN PHOSPHATE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0006-0080"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-0080
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=64beb3d2-3aeb-4cd5-ba11-dacf6c9a5b50